Biontech Se ADR (BNTX) Stock Price, Quote & News

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology

Sector: Healthcare

Phone: 49 6131 9084

Fax: 49 6131 9084

Website: www.biontech.de

Address:

An der Goldgrube 12, Mainz, Germany

positive_thinking Sep. 17 at 8:16 PM

$NVAX $PFE $BNTX $MRNA Huge news for novavax $NVAX. Don’t be surprised when it will be the only covid vaccine which survives as it’s currently the only non mRNA technology based corona vaccine. No child died as it has never been approved for kids under 12. no side effects, lasts 2x longer. It’s the safest choice we currently have. Over and out https://x.com/NewXvg/status/1968063552511463461?t=Ne-ZJrgSM7Kzi2GYG1lMzA&s=19

1 · Reply

positive_thinking Sep. 17 at 8:13 PM

$NVAX $PFE $BNTX $MRNA Dr. Anthony Fauci called back before Congress after his requests to ‘delete’ government emails uncovered by Sen. Rand Paul https://nypost.com/2025/09/11/us-news/fauci-called-back-before-congress-after-his-requests-to-delete-government-emails-uncovered-by-sen-paul/

0 · Reply

jogabonito84 Sep. 17 at 2:32 PM

$IBRX $BNTX $MRK $TSLA $NVDA https://stocktwits.com/news-articles/equity/markets/immunitybio-stock-breaks-out-3-analyst-bullish-signals/chDG0VnRdCV

0 · Reply

taxplanr Sep. 17 at 1:29 PM

$BNTX $PFE disclose how malignantRNA can add faulty genes on their website https://www.thekingstonreport.com/p/mrna-technology-can-add-faulty-genes-962?utm_source=post-email-title&publication_id=1103773&post_id=173717465&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

BillionerOfKing Sep. 17 at 12:39 PM

$BNTX Current Stock Price: $99.24 Contracts to trade: $100 BNTX Sep 19 2025 Call Entry: $1.72 Exit: $2.46 ROI: 43% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

taxplanr Sep. 17 at 10:45 AM

malignantRNA last desperate attempt will highlight why they are being pulled off the market $BNTX $MRNA $PFE Last chance for dumping https://www.newsnationnow.com/politics/cassidy-to-amplify-rfk-jr-criticism-with-hearing-on-cdc-turmoil/

1 · Reply

growmagnun Sep. 16 at 11:49 PM

$BNTX So proud of the NY Governer for still Trusting The Science

0 · Reply

cielo1 Sep. 16 at 10:50 PM

$BNTX $MRNA $PFE Remove vaccine liabiltiy now! Massive DNA contamination in the COVID Vaxxx! https://youtu.be/ak5LarSfl8s?feature=shared

1 · Reply

Olddrache Sep. 16 at 2:50 PM

$MRNA $PFE $BNTX

0 · Reply

taxplanr Sep. 16 at 1:05 PM

Study of biochips found in COVID-19 vaccines. Part 2 - Based on microscopic studies by Dr. Diana Wojtkowiak $BNTX $MRNA $PFE https://anamihalceamdphd.substack.com/p/study-of-biochips-found-in-covid-30f?utm_source=post-email-title&publication_id=956088&post_id=173602066&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

Sep 8, 2025, 2:01 PM EDT - 9 days ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

Sep 8, 2025, 11:05 AM EDT - 9 days ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

Sep 8, 2025, 11:00 AM EDT - 9 days ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 7:02 AM EDT - 9 days ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Sep 8, 2025, 6:45 AM EDT - 9 days ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

Sep 5, 2025, 5:13 AM EDT - 12 days ago

BioNTech, Duality score initial trial win with breast cancer precision drug

Aug 28, 2025, 6:20 AM EDT - 20 days ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Aug 27, 2025, 12:50 PM EDT - 21 days ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

Aug 7, 2025, 9:00 PM EDT - 5 weeks ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

Aug 5, 2025, 1:36 PM EDT - 6 weeks ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 4, 2025, 1:56 PM EDT - 6 weeks ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:32 AM EDT - 6 weeks ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 7:01 AM EDT - 6 weeks ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 6:52 AM EDT - 6 weeks ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:45 AM EDT - 6 weeks ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 1, 2025, 4:51 PM EDT - 6 weeks ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Aug 1, 2025, 8:31 AM EDT - 6 weeks ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 6:54 AM EDT - 6 weeks ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 5:59 AM EDT - 6 weeks ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Jul 31, 2025, 7:00 AM EDT - 6 weeks ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Jul 25, 2025, 2:30 AM EDT - 7 weeks ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 7 weeks ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

Jul 23, 2025, 4:11 AM EDT - 2 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

Jul 21, 2025, 6:45 AM EDT - 2 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 17, 2025, 8:30 AM EDT - 2 months ago

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Jul 10, 2025, 7:18 AM EDT - 2 months ago

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

MRNA PFE

Jun 16, 2025, 3:06 PM EDT - 3 months ago

5 Stocks To Ride The German Market Rally

FMS SAP

Jun 12, 2025, 11:07 AM EDT - 3 months ago

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

CVAC

Jun 12, 2025, 7:11 AM EDT - 3 months ago

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

CVAC

Jun 12, 2025, 7:03 AM EDT - 3 months ago

BioNTech to acquire CureVac in $1.25 billion all-stock deal

CVAC

Jun 12, 2025, 6:45 AM EDT - 3 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Jun 10, 2025, 11:50 AM EDT - 3 months ago

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

MRK MRNA PFE

Jun 10, 2025, 10:45 AM EDT - 3 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

MRNA NVAX PFE

Jun 10, 2025, 9:30 AM EDT - 3 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

MRNA NVAX PFE

Jun 10, 2025, 8:18 AM EDT - 3 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

MRNA NVAX PFE SNY

Jun 6, 2025, 7:00 AM EDT - 3 months ago

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

BMY

Jun 3, 2025, 3:34 PM EDT - 3 months ago

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

AZN GILD PFE AMGN BMY MRK

Jun 2, 2025, 3:50 PM EDT - 3 months ago

Bristol Myers CEO explains why he's spending billions on BioNTech deal

BMY

Jun 2, 2025, 2:51 PM EDT - 3 months ago

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

BMY BPMC MRK SNY

Jun 2, 2025, 12:22 PM EDT - 3 months ago

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

BMY

Jun 2, 2025, 11:08 AM EDT - 3 months ago

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

BMY

Jun 2, 2025, 8:46 AM EDT - 3 months ago

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

BMY

Jun 2, 2025, 7:42 AM EDT - 3 months ago

BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb

BMY

Jun 2, 2025, 6:50 AM EDT - 3 months ago

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership

BMY

May 27, 2025, 8:15 AM EDT - 4 months ago

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

May 20, 2025, 9:09 AM EDT - 4 months ago

BioNTech plans up to $1.33 billion investment in the United Kingdom

May 7, 2025, 11:13 AM EDT - 4 months ago

New vaccine chief rocks pharmaceutical stocks

MRNA NVAX PFE GSK IBB SRPT XBI

May 6, 2025, 7:45 AM EDT - 4 months ago

BioNTech: mRNA Challenges Amid Regulatory Uncertainty (Rating Downgrade)

May 5, 2025, 3:49 PM EDT - 4 months ago

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

positive_thinking Sep. 17 at 8:16 PM

1 · Reply

positive_thinking Sep. 17 at 8:13 PM

0 · Reply

jogabonito84 Sep. 17 at 2:32 PM

$IBRX $BNTX $MRK $TSLA $NVDA https://stocktwits.com/news-articles/equity/markets/immunitybio-stock-breaks-out-3-analyst-bullish-signals/chDG0VnRdCV

0 · Reply

taxplanr Sep. 17 at 1:29 PM

0 · Reply

BillionerOfKing Sep. 17 at 12:39 PM

0 · Reply

taxplanr Sep. 17 at 10:45 AM

1 · Reply

growmagnun Sep. 16 at 11:49 PM

$BNTX So proud of the NY Governer for still Trusting The Science

0 · Reply

cielo1 Sep. 16 at 10:50 PM

$BNTX $MRNA $PFE Remove vaccine liabiltiy now! Massive DNA contamination in the COVID Vaxxx! https://youtu.be/ak5LarSfl8s?feature=shared

1 · Reply

Olddrache Sep. 16 at 2:50 PM

$MRNA $PFE $BNTX

0 · Reply

taxplanr Sep. 16 at 1:05 PM

0 · Reply

taxplanr Sep. 16 at 3:09 AM

Study of biochips found in COVID-19 vaccines parts 1-3. Part 1 - Based on photos by David Nixon. Dr. Diana Wojtkowiak $BNTX $MRNA $PFE https://anamihalceamdphd.substack.com/p/study-of-biochips-found-in-covid?utm_source=post-email-title&publication_id=956088&post_id=173596947&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

Snickers0077 Sep. 15 at 6:05 PM

$BNTX

1 · Reply

growmagnun Sep. 15 at 2:09 PM

$BNTX Dead cat went to 98.66

0 · Reply

ZacksResearch Sep. 15 at 1:47 PM

$MRNA, $BNTX, $PFE, and $NVAX stocks tumbled — is the future of COVID-19 vaccine makers in jeopardy? ⚠️ Investors reacted to reports linking COVID-19 vaccines to pediatric deaths, sparking concerns over renewed regulatory attention. Moderna and BioNTech dropped over 7%, while Pfizer and Novavax slipped nearly 4%. Discover the potential impact on vaccine makers 👉 https://www.zacks.com/stock/news/2751283/covid-19-vaccine-stocks-fall-on-reports-linking-shots-to-child-deaths?cid=sm-stocktwits-2-2751283-body-12364&ADID=SYND_STOCKTWITS_TWEET_2_2751283_BODY_12364

0 · Reply

radham Sep. 15 at 1:25 PM

$BNTX BMO to $143 https://finance.yahoo.com/news/bmo-capital-maintains-buy-biontech-051658844.html

0 · Reply

ZacksResearch Sep. 15 at 12:47 PM

$MRNA, $BNTX, $PFE, $NVAX — vaccine stocks just got hit hard ⚠️ Reports suggest health officials are preparing to link COVID-19 vaccines to child deaths, with a key CDC meeting looming. Full story and implications here 👉 https://www.zacks.com/stock/news/2751283/covid-19-vaccine-stocks-fall-on-reports-linking-shots-to-child-deaths?cid=sm-stocktwits-2-2751283-teaser-12362&ADID=SYND_STOCKTWITS_TWEET_2_2751283_TEASER_12362

3 · Reply

ripster47 Sep. 15 at 12:38 PM

🚨🚨 TRUMP OFFICIALS TO LINK CHILD DEATHS TO COVID SHOTS: WAPO $MRNA $PFE $NVAX $BNTX

0 · Reply

radham Sep. 15 at 11:30 AM

$BNTX will cure cancer and soar to $2000 a share

0 · Reply

taxplanr Sep. 15 at 11:27 AM

Very important for jab victims to know their spike antibody levels $BNTX $MRNA $PFE https://www.thefocalpoints.com/p/importance-of-knowing-anti-spike

1 · Reply

ChartMill Sep. 15 at 7:53 AM

$ORCL 🔻 –5% … the AI rocketship is cooling fast after retail dumped into the hype. $PFE -3.98%, $MRNA -7.40%, $BNTX -7.26% – RFK Jr. headlines nuked vax plays. $WBD +17% – takeover chatter still buzzing. ⚠️ Sept 17 Fed cut is the next big catalyst. Stay nimble. https://www.chartmill.com/news/FIG/Chartmill-34332-Oracle-Retreats-Fed-Rate-Cut-Looms-and-Vaccine-Politics-Shake-Pharma-Stocks

0 · Reply

Trackdips Sep. 14 at 4:53 PM

$BE $BNTX $CRWV $RCAT

1 · Reply

Trackdips Sep. 14 at 4:53 PM

$BNTX

0 · Reply

Market Cap	23.86B
Revenue (ttm)	2.98B
Net Income (ttm)	-719.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.18%
Debt to Equity Ratio	0.01

Volume	1,034,000
Avg Vol	883,714
Day's Range	N/A - N/A
Shares Out	240.40M
Stochastic %K	32%
Beta	1.39
Analysts	Strong Sell
Price Target	$135.41